CD19 and neoplasm: We chose to re-derive immune signature marker sets directly from TCGA tumor data using a handful of sentinel markers (FOXP3, CD8A, CD19, etc.)for immune cells and utilizing mutual rank distance metrics to expand the local gene expression neighborhoods[23].